Section 4: Clinical Pharmacy Services 2018
DOI: 10.1136/ejhpharm-2018-eahpconf.276
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-186 Vision-related quality of life in patients diagnosed with retinal pathology

Abstract: BackgroundThe retinal pathologies, main causes of blindness, produce a negative impact on patients’ vision-related quality of life (vrQoL).PurposeTo describe the baseline vrQoL in patients diagnosed with neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DME) or branch/central retinal vein occlusion (B/CRVO).Material and methodsObservational, prospective study, from February 2014 to December 2016.Patients diagnosed with nAMD, DME or B/CRVO, who began with intravitreal ranibizumab and… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles